Related Experiment Video

Updated: Jan 29, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

8.0K

Next-Generation ERα Inhibitors for Endocrine-Resistant ER+ Breast Cancer

Sean W Fanning1, Geoffrey L Greene1

  • 1Ben May Department for Cancer Research, The University of Chicago, Chicago, Illinois.

Endocrinology
|February 13, 2019
PubMed

Insights

Next-generation endocrine therapies, like selective estrogen receptor (ER) degraders, show promise in overcoming acquired resistance in ERα-positive breast cancer, effectively shrinking tumors and preventing metastasis.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Estrogen receptor-α (ERα) is a key target in ~70% of breast cancer cases.
  • Endocrine therapies targeting ERα are standard for preventing breast cancer progression and metastasis.
  • Acquired resistance limits the long-term efficacy of current endocrine treatments.

Purpose of the Study:

  • To review mechanisms of acquired endocrine resistance in luminal breast cancers.
  • To discuss next-generation endocrine therapies designed to overcome this resistance.
  • To highlight the role of selective ER degraders in treating resistant breast cancer.

Main Methods:

  • Review of preclinical models of endocrine-resistant metastatic breast cancer.
  • Analysis of antiestrogen efficacy and potency in overcoming resistance.
  • Examination of therapies that antagonize ERα actions and induce its degradation.

Main Results:

  • Next-generation antiestrogens demonstrate improved efficacy and potency against resistant tumors.
  • Selective ER degraders show substantial antitumor efficacy in preclinical models.
  • These agents can shrink tumors and prevent metastasis in endocrine-resistant settings.

Conclusions:

  • Acquired endocrine resistance is a significant challenge in ERα-positive breast cancer treatment.
  • Next-generation endocrine therapies, particularly selective ER degraders, offer a promising strategy to overcome resistance.
  • Targeting ERα degradation represents a key approach for improving treatment outcomes in resistant breast cancer.

More Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.9K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.0K

Related Concept Videos

Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
What is the Endocrine System?00:46

What is the Endocrine System?

The endocrine system sends hormones—chemical signals—through the bloodstream to target cells—the cells the hormones selectively affect. These signals are produced in endocrine cells, secreted into the extracellular fluid, and then diffuse into the blood. Eventually, they diffuse out of the blood and bind to target cells which have specialized receptors to recognize the hormones.
420.4K
The Endocrine System01:29

The Endocrine System

The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that...
1.3K
An Overview of the Endocrine System01:10

An Overview of the Endocrine System

The endocrine system, a complex network of glands, orchestrates physiological balance within the body through the production and secretion of hormones. These hormones are chemical messengers in intercellular communication, acting as conduits between the secretory cells and distant target sites. They traverse the circulatory system by being released into the extracellular fluid, and their impact is specific to cells possessing receptors for a particular hormone.
The endocrine system collaborates...
14.1K
Structures of the Endocrine System00:59

Structures of the Endocrine System

The intricate framework of the endocrine system encompasses a diverse array of glands, with their target tissues and organs strategically distributed throughout the body. Central to this network are the endocrine glands, specialized structures that lack ducts and release hormones directly into the interstitial fluid. Notably, the hypothalamus, a vital neuroendocrine organ situated in the brain, governs neural functions and serves as a potent source of hormonal regulation. Near the hypothalamus...
12.1K